These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer. Ohtsuka T, Nomori H, Ebihara A, Watanabe K, Kaji M, Naruke T, Suemasu K, Uno K. Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929 [Abstract] [Full Text] [Related]
6. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT. Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [Abstract] [Full Text] [Related]
8. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up? Chen W, Jian W, Li HT, Li C, Zhang YK, Xie B, Zhou DQ, Dai YM, Lin Y, Lu M, Huang XQ, Xu CX, Chen L. Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042 [Abstract] [Full Text] [Related]
15. Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better? Wu LM, Xu JR, Gu HY, Hua J, Chen J, Zhang W, Haacke EM, Hu J. J Surg Res; 2012 Nov; 178(1):304-14. PubMed ID: 22541065 [Abstract] [Full Text] [Related]
16. High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging. Picchio M, Mangili G, Samanes Gajate AM, De Marzi P, Spinapolice EG, Mapelli P, Giovacchini G, Sigismondi C, Viganò R, Sironi S, Messa C. Nucl Med Commun; 2010 Jun; 31(6):506-12. PubMed ID: 20168262 [Abstract] [Full Text] [Related]
17. Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging. Li M, Wu N, Liu Y, Zheng R, Liang Y, Zhang W, Zhao P. Eur J Radiol; 2012 Aug; 81(8):1886-90. PubMed ID: 21511421 [Abstract] [Full Text] [Related]